表紙:放射線皮膚炎の世界市場:産業分析、動向、市場規模、および予測(~2027年)
市場調査レポート
商品コード
1063728

放射線皮膚炎の世界市場:産業分析、動向、市場規模、および予測(~2027年)

Radiodermatitis Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027

出版日: | 発行: Infinium Global Research (IGR) | ページ情報: 英文 100 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=135.89円
放射線皮膚炎の世界市場:産業分析、動向、市場規模、および予測(~2027年)
出版日: 2022年02月28日
発行: Infinium Global Research (IGR)
ページ情報: 英文 100 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の放射線皮膚炎の市場規模は、2021年から2027年の予測期間において4.43%のCAGRで成長すると予測されています。

当レポートでは、世界の放射線皮膚炎市場を調査しており、市場の概要、市場規模や予測、動向、成長要因および阻害要因、製品・投与経路・流通チャネル・地域別の分析など包括的な情報を提供しています。

目次

第1章 序文

  • レポートの説明
  • 調査方法
  • 調査アプローチ

第2章 エグゼクティブサマリー

  • 放射線皮膚炎市場のハイライト
  • 放射線皮膚炎市場の予測
  • 放射線皮膚炎市場、地域のハイライト

第3章 世界の放射線皮膚炎市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 放射線皮膚炎市場に対するCOVID-19の影響の分析
  • ポーターのファイブフォース分析
  • IGR:成長マトリックス分析
    • IGR:製品別の成長マトリックス分析
    • IGR:投与経路別の成長マトリックス分析
    • IGR:流通チャネル別の成長マトリックス分析
    • IGR:地域別の成長マトリックス分析
  • 放射線皮膚炎市場のバリューチェーン分析

第4章 放射線皮膚炎市場のマクロ指標分析

第5章 製品別の世界の放射線皮膚炎市場

  • 親水性クリーム
  • 抗生物質
  • 被覆材 (ドレッシング)
  • ハイドロゲル・ハイドロコロイド
  • コルチコステロイド
  • シリコーンコーティング
  • 針なしバリアフィルム

第6章 投与経路別の世界の放射線皮膚炎市場

  • 局所
  • 経口

第7章 流通チャネル別の世界の放射線皮膚炎市場

  • 病院
  • がん専門クリニック
  • 研究機関
  • その他

第8章 地域別の世界の放射線皮膚炎市場(2021年~2027年)

  • 北米
    • 北米の放射線皮膚炎市場:製品別
    • 北米の放射線皮膚炎市場:投与経路別
    • 北米の放射線皮膚炎市場:流通チャネル別
    • 北米の放射線皮膚炎市場:国別
  • 欧州
    • 欧州の放射線皮膚炎市場:製品別
    • 欧州の放射線皮膚炎市場:投与経路別
    • 欧州の放射線皮膚炎市場:流通チャネル別
    • 欧州の放射線皮膚炎市場:国別
  • アジア太平洋
    • アジア太平洋の放射線皮膚炎市場:製品別
    • アジア太平洋の放射線皮膚炎市場:投与経路別
    • アジア太平洋の放射線皮膚炎市場:流通チャネル別
    • アジア太平洋の放射線皮膚炎市場:国別
  • その他地域
    • その他地域の放射線皮膚炎市場:製品別
    • その他地域の放射線皮膚炎市場:投与経路別
    • その他地域の放射線皮膚炎市場:流通チャネル別
    • その他地域の放射線皮膚炎市場:小地域別

第9章 企業プロファイルと競合情勢

  • 世界の放射線皮膚炎市場の競合情勢
  • 企業プロファイル
    • 3M Company
    • Molnlycke
    • HARTMANN
    • KeraNetics, Inc
    • Smith & Nephew Plc
    • Charles River Laboratories
    • The Jackson Laboratory
    • Stratpharma
    • InterMed S.A
    • AceTech
目次
Product Code: HC08752

The report on the global radiodermatitis market provides qualitative and quantitative analysis for the period from 2019 to 2027. The report predicts the global radiodermatitis market to grow with a CAGR of 4.43% over the forecast period from 2021-2027. The study on radiodermatitis market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2019 to 2027.

The report on radiodermatitis market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global radiodermatitis market over the period of 2019 to 2027. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global radiodermatitis market over the period of 2019 to 2027. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Surging cases of cancer around the globe.
  • Increasing adoption of radiotherapy among people.
  • Rising number of public and private healthcare organizations consistently try to promote awareness about radiodermatitis management and treatment.

2) Restraints

  • The people of underdeveloped countries lack information exposure about acute or chronic radiodermatitis.

3) Opportunities

  • The peoples of developed countries have growing awareness about enhancing their quality of life.
  • Enormous expansion of healthcare establishments across the globe.

Research Methodology

A) Primary Research

Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include:

  • 1. Key Opinion Leaders associated with Infinium Global Research
  • 2. Internal and External subject matter experts
  • 3. Professionals and participants from the industry

Our primary research respondents typically include:

  • 1. Executives working with leading companies in the market under review
  • 2. Product/brand/marketing managers
  • 3. CXO level executives
  • 4. Regional/zonal/ country managers
  • 5. Vice President level executives.

B) Secondary Research

Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include:

  • 1. Company reports and publications
  • 2. Government/institutional publications
  • 3. Trade and associations journals
  • 4. Databases such as WTO, OECD, World Bank, and among others.
  • 5. Websites and publications by research agencies

Segment Covered

The global radiodermatitis market is segmented on the basis of product, route of administration, and distribution channels.

The Global Radiodermatitis Market by Product

  • Hydrophilic Creams
  • Antibiotics
  • Dressings
  • Hydrogel & Hydrocolloid
  • Corticosteroids
  • Silicone Coated
  • No Sting Barrier Film

The Global Radiodermatitis Market by Route Of Administration

  • Topical
  • Oral

The Global Radiodermatitis Market by Distribution Channels

  • Hospitals
  • Cancer Specialty Clinics
  • Research Institutes
  • Others

Company Profiles

The companies covered in the report include:

  • 3M Company
  • Molnlycke
  • HARTMANN
  • KeraNetics, Inc
  • Smith & Nephew Plc
  • Charles River Laboratories
  • The Jackson Laboratory
  • Stratpharma
  • InterMed S.A
  • AceTech

What does this Report Deliver?

  • 1. Comprehensive analysis of the global as well as regional markets of the radiodermatitis market.
  • 2. Complete coverage of all the segments in the radiodermatitis market to analyze the trends, developments in the global market and forecast of market size up to 2027.
  • 3. Comprehensive analysis of the companies operating in the global radiodermatitis market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
  • 4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Research Methods
  • 1.3. Research Approaches

2. Executive Summary

  • 2.1. Radiodermatitis Market Highlights
  • 2.2. Radiodermatitis Market Projection
  • 2.3. Radiodermatitis Market Regional Highlights

3. Global Radiodermatitis Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
    • 3.2.2. Restraints
    • 3.2.3. Opportunities
  • 3.3. Analysis of COVID-19 impact on the Radiodermatitis Market
  • 3.4. Porter's Five Forces Analysis
  • 3.5. IGR-Growth Matrix Analysis
    • 3.5.1. IGR-Growth Matrix Analysis by Product
    • 3.5.2. IGR-Growth Matrix Analysis by Route of Administration
    • 3.5.3. IGR-Growth Matrix Analysis by Distribution Channels
    • 3.5.4. IGR-Growth Matrix Analysis by Region
  • 3.6. Value Chain Analysis of Radiodermatitis Market

4. Radiodermatitis Market Macro Indicator Analysis

5. Global Radiodermatitis Market by Product

  • 5.1. Hydrophilic Creams
  • 5.2. Antibiotics
  • 5.3. Dressings
  • 5.4. Hydrogel & Hydrocolloid
  • 5.5. Corticosteroids
  • 5.6. Silicone Coated
  • 5.7. No Sting Barrier Film

6. Global Radiodermatitis Market by Route of Administration

  • 6.1. Topical
  • 6.2. Oral

7. Global Radiodermatitis Market by Distribution Channels

  • 7.1. Hospitals
  • 7.2. Cancer Specialty Clinics
  • 7.3. Research Institutes
  • 7.4. Others

8. Global Radiodermatitis Market by Region 2021-2027

  • 8.1. North America
    • 8.1.1. North America Radiodermatitis Market by Product
    • 8.1.2. North America Radiodermatitis Market by Route of Administration
    • 8.1.3. North America Radiodermatitis Market by Distribution Channels
    • 8.1.4. North America Radiodermatitis Market by Country
  • 8.2. Europe
    • 8.2.1. Europe Radiodermatitis Market by Product
    • 8.2.2. Europe Radiodermatitis Market by Route of Administration
    • 8.2.3. Europe Radiodermatitis Market by Distribution Channels
    • 8.2.4. Europe Radiodermatitis Market by Country
  • 8.3. Asia-Pacific
    • 8.3.1. Asia-Pacific Radiodermatitis Market by Product
    • 8.3.2. Asia-Pacific Radiodermatitis Market by Route of Administration
    • 8.3.3. Asia-Pacific Radiodermatitis Market by Distribution Channels
    • 8.3.4. Asia-Pacific Radiodermatitis Market by Country
  • 8.4. RoW
    • 8.4.1. RoW Radiodermatitis Market by Product
    • 8.4.2. RoW Radiodermatitis Market by Route of Administration
    • 8.4.3. RoW Radiodermatitis Market by Distribution Channels
    • 8.4.4. RoW Radiodermatitis Market by Sub-region

9. Company Profiles and Competitive Landscape

  • 9.1. Competitive Landscape in the Global Radiodermatitis Market
  • 9.2. Companies Profiles
    • 9.2.1. 3M Company
    • 9.2.2. Molnlycke
    • 9.2.3. HARTMANN
    • 9.2.4. KeraNetics, Inc
    • 9.2.5. Smith & Nephew Plc
    • 9.2.6. Charles River Laboratories
    • 9.2.7. The Jackson Laboratory
    • 9.2.8. Stratpharma
    • 9.2.9. InterMed S.A
    • 9.2.10. AceTech